Minze Health
Minze Health NV is a Belgian digital health company that develops a digital urology platform combining home-based uroflowmetry devices, automated bladder diaries, and app-based behavioral therapy for male LUTS/BPH and overactive bladder patients, sold to hospitals, urology clinics, and clinicians across EMEA and the United States.
- Company typePrivate
- Founded2015
- HeadquartersAntwerp, Belgium
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Minze Health does
Minze Health NV is a Belgian digital health company founded in 2015 and headquartered in Antwerp, with a secondary US office in Wilmington, Delaware. The company develops a digital urology platform that integrates home-based and in-clinic diagnostics with digital therapeutics, targeting male lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH), as well as overactive bladder (OAB). Its commercial product portfolio comprises the Homeflow home-based uroflowmetry device with integrated bladder diary and IPSS scoring for male LUTS/BPH, the Diary Pod automated bladder diary device for OAB diagnostics, the Minze LUTS/BPH Digital Therapy (a 13-week app-based behavioral therapy program), and the Minze Portal clinician-facing platform that aggregates patient data and tracks therapy adherence. A Minze OAB Digital Therapy is in clinical development.
The platform combines proprietary hardware (Homeflow, Diary Pod) with a software ecosystem that captures multi-day voiding behavior data at home and delivers structured behavioral therapy via mobile app. All diagnostic data flows automatically into the Minze Portal, enabling clinicians to review objective reports rather than relying on subjective paper logs or single-visit uroflowmetry snapshots. The company is ISO 13485:2016 certified and a member of AdvaMed.
Minze Health generates revenue through hardware device sales to hospitals and clinics, recurring digital therapeutics subscriptions, and channel partnership revenue. Distribution is hybrid: direct enterprise sales to hospitals and urology practices (deployed across nearly 300 hospitals worldwide), and a three-year EMEA distribution partnership with Medtronic for the Diary Pod tied to Medtronic's Interstim sacral neuromodulation franchise. The company is actively expanding into the US market with prescription digital therapeutics, supported by a $5.3 million funding round raised in October 2024.
Minze Health firmographics
Firmographics- Name
- Minze Health
- Legal name
- Minze Health NV
- Website
- https://minzehealth.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Minze Health NV is a Belgian digital health company that develops a digital urology platform combining home-based uroflowmetry devices, automated bladder diaries, and app-based behavioral therapy for male LUTS/BPH and overactive bladder patients, sold to hospitals, urology clinics, and clinicians across EMEA and the United States.
- Ownership category
- akta.pro rank
Minze Health industry classification
Industry- Product category
- Urology Medical Devices
- NAICS
- Health Care and Social Assistance (62)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Urology Telemedicine Platforms (HLALAGAN)
- akta.pro secondary industry
- Software as a Medical Device (SaMD) – Clinical Decision & Diagnostic Software (HLACANAD)
Keywords
Where Minze Health is headquartered
LocationHeadquarters
- HQ city
- Antwerp
- HQ country
- Belgium
- HQ region
- Europe
Offices2 records
Markets served
Minze Health business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales
Revenue model
- Medical Device Sales: Sale of hardware devices including Homeflow and Diary Pod to hospitals, clinics, and healthcare providers for diagnostic purposes.
- Digital Therapeutics Subscription: Prescription digital therapeutics delivered via app-based platform, likely sold as subscription to healthcare providers or health systems.
- Distribution Partnership Revenue: Revenue generated through Medtronic partnership for distribution of Diary Pod across EMEA markets.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
Minze Health product offering
Product offeringCore offering
Minze Health builds a digital urology platform combining proprietary medical devices (Homeflow home-based uroflowmetry and Diary Pod automated bladder diary) with app-based digital behavioral therapy programs for male Lower Urinary Tract Symptoms (LUTS), Benign Prostatic Hyperplasia (BPH), and Overactive Bladder (OAB). Diagnostic data flows automatically from devices into the Minze Portal, a clinician-facing platform used by hospitals and urology clinics for patient monitoring and treatment.
Product overview
Minze Health offers a unified digital health platform integrating digital diagnostics and therapeutics for male LUTS/BPH and OAB. The product portfolio consists of three core commercial products: Homeflow (home-based uroflowmetry device for LUTS/BPH diagnostics), Diary Pod (automated bladder diary for OAB diagnostics), and Minze LUTS/BPH Digital Therapy (13-week app-based behavioral therapy). An OAB Digital Therapy is currently in clinical development. All diagnostic devices connect to the Minze Portal, a clinician-facing platform that automatically receives device reports and enables patient monitoring. The products work together to provide a complete pathway from symptom assessment to treatment, combining in-clinic and home-based diagnostics with scalable digital therapies.
Differentiator
Problem solved
Functional benefit
Products and services
- Homeflow Home-based uroflowmetry device for non-invasive Male LUTS/BPH diagnostics. Combines uroflowmetry, bladder diary, and IPSS scoring in a single home device; patient measures from home over multiple days and reports flow automatically into the Minze Portal for clinician review.
- Diary Pod Automated bladder diary device for OAB (Overactive Bladder) diagnostics. Captures voided volume and time automatically and pairs with the Flow app for patients to tag urgency and intake, producing a 2-3 day automated diary that flows into the Minze Portal.
- Minze LUTS/BPH Digital Therapy 13-week evidence-based app-based digital behavioral therapy program for Male LUTS and BPH. Includes weekly modules, daily tips, bladder training, lifestyle guidance, objective symptom tracking, and a clinician dashboard for monitoring progress and adherence.
- Minze Portal Clinician-facing web portal that automatically ingests reports from Homeflow and Diary Pod devices and presents ready-to-review patient data, enabling clinicians to monitor diagnostic results, therapy adherence, and patient progress.
Quantifiable outcome
- 80 million adults affected by LUTS in the U.S.; over 90 million in the EU
- +2 more outcomes
Companies that use Minze Health
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles1 record
Minze Health technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Minze Health partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Medtronic plccoreMinze Health NV signed a three-year partnership agreement with Medtronic to distribute Minze's app-controlled urine collection device (Diary Pod) across EMEA markets. The Diary Pod is designed to support patients with overactive bladder receiving sacral neuromodulation therapy with Medtronic's Interstim system. The deal enhances Medtronic's urology portfolio while expanding Minze's commercial reach through an established medtech distribution partner.
Scale indicators4 records
Recent moves6 records
Expansion highlights8 records
Minze Health competitors and assessment
Company assessmentDirect peers
- iUFlow: iUFlow offers a home-based uroflowmetry device with companion app for bladder monitoring, making it the closest direct competitor to Minze's Homeflow in remote urology diagnostics.
- Pelvital: Pelvital develops FDA-cleared medical devices and digital tools for pelvic floor disorders including urinary incontinence, overlapping with Minze's OAB and pelvic health focus area.
- MediTuner: MediTuner builds app-based digital therapeutics for urinary incontinence and related conditions, directly overlapping Minze's OAB and LUTS/BPH behavioral therapy offerings.
Emerging players
- Bold Health (Mahana Therapeutics): Bold Health/Mahana develops prescription digital therapeutics for chronic GI and related conditions, sharing Minze's DTx business model and regulatory pathway into prescription digital therapy.
- Kaia Health: Kaia Health is a European-headquartered digital therapeutics company offering app-based behavioral therapy programs for MSK pain and COPD, comparable as a peer European DTx scale-up.
- Sword Health: Sword Health is a digital musculoskeletal therapy leader with a similar prescription DTx go-to-market model, comparable as a peer in the digital therapeutics commercialization playbook.
- Augury: Augury combines proprietary hardware sensors with AI-driven software analytics in industrial/health monitoring, sharing Minze's hardware-plus-software-platform commercialization approach.
Broad incumbents
- Laborie Medical Technologies: Laborie is a global urology and pelvic health medical device incumbent with established uroflowmetry and urodynamics products, competing with Minze's diagnostic devices in hospital channels.
- Coloplast: Coloplast is a global leader in urology and continence care products, with installed relationships across urology practices that Minze must penetrate to scale its OAB and BPH solutions.
- Boston Scientific: Boston Scientific has a large urology portfolio (including prostate and OAB therapies) and the R&D and clinical-trial capacity to enter adjacent digital diagnostics, representing a significant competitive threat.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights6 records
Customer concentration
Minze Health social profiles
Digital presenceMinze Health compliance and trust
Trust signalCompliance1 record
Minze Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
Minze Health leadership team
Management profileNumber of profiles
Profiles5 records
Minze Health funding detail
Funding detailFunding overview
Funding rounds2 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Minze Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Minze Health
What does Minze Health do?
Minze Health builds a digital urology platform combining proprietary medical devices (Homeflow home-based uroflowmetry and Diary Pod automated bladder diary) with app-based digital behavioral therapy programs for male Lower Urinary Tract Symptoms (LUTS), Benign Prostatic Hyperplasia (BPH), and Overactive Bladder (OAB). Diagnostic data flows automatically from devices into the Minze Portal, a clinician-facing platform used by hospitals and urology clinics for patient monitoring and treatment.
Is Minze Health a public or private company?
Minze Health is a private company. It is classified as venture growth investor backed and is currently operating.
When was Minze Health founded?
Minze Health was founded in 2015. It employs 11 to 50 people.
Where is Minze Health based?
Minze Health is headquartered in Antwerp, Belgium, in the Europe region.
How does Minze Health make money?
Three revenue lines are on record. Medical Device Sales are the primary driver. The others are digital Therapeutics Subscription and distribution Partnership Revenue.
Who are Minze Health's main competitors?
Direct peers on record are iUFlow, Pelvital and MediTuner. Emerging players are Bold Health (Mahana Therapeutics), Kaia Health, Sword Health and Augury. Broad incumbents are Laborie Medical Technologies, Coloplast and Boston Scientific.
Does Minze Health have an API?
No public API is recorded for Minze Health.
What industry is Minze Health in?
Minze Health's product category is Urology Medical Devices. Its primary akta.pro industry code is HLALAGAN, Urology Telemedicine Platforms, with a secondary code of HLACANAD, Software as a Medical Device (SaMD) – Clinical Decision & Diagnostic Software. Its NAICS code is 62 and its SIC code is 3841.